The following limitations apply to the 850 and 860 systems:
Avoid hemolyzed samples, because they falsely elevate potassium levels due to
intra-erythrocyte potassium levels.
Avoid samples with elevated levels of salicylates, salicylate derivatives such as
ibuprofen, and bromide (Br
–
), because they falsely elevate chloride levels.
Avoid samples contaminated with perchlorate (ClO
4
–
), thiocyanate (SCN
–
),
iodide (I
–
), and nitrate (NO
3
–
), because they falsely elevate chloride levels.
Avoid using excessive levels of heparin anticoagulants. Excessive levels of
heparin anticoagulants cause calcium-heparin chelation and falsely decrease
calcium levels.
The following limitations apply only to the 860 system:
Avoid using sample collection devices containing fluoride/oxalate anticoagulants
(the gray top tube). These anticoagulants have a significant effect on glucose and
lactate.
The 800 system can analyze samples obtained from the following sources:
arterial blood
Arterial blood is commonly recommended for use in blood gas
studies because it accurately reflects acid-base physiology and
oxygenation status.
Arterial blood is routinely obtained from the radial, femoral, or
brachial arteries. Other sites can be used following catheterization or
surgical procedure
s.
venous blood
Venous blood can provide satisfactory pH and pCO
2
values;
however, venous pO
2
values may not be significant in routine
clinical study without simultaneous study of arterial pO
2
.
Venous blood is routinely obtained from an antecubital vein using
vacuum tube collection systems. Other sites can be used as necessary.
Venous oxygen saturation values reported must be so labeled to
ensure correct interpretation of the results.
mixed venous
blood
Mixed venous (pulmonary artery) blood may be obtained from a
pulmonary artery catheter after carefully clearing the catheter of
infusion fluid. Take appropriate precautions to prevent mixing of
pulmonary capillary blood with the pulmonary artery blood.
Summary of Contents for Rapidlab 800
Page 1: ...2000 Bayer Corporation All rights reserved 115701 Rev C 4 2000...
Page 13: ......
Page 14: ......
Page 20: ......
Page 21: ......
Page 22: ......
Page 23: ...3 3 0 3 3 3 3 1 3 1 3 3 3 3 3 12 3 3 1 1 3 1 3 3 1 3 3 12 3 3 3 1 1 3 1 3 3...
Page 25: ......
Page 26: ......
Page 33: ...CO ox Pump CO ox Module Sample Chamber Hemolyzer...
Page 34: ...Power Input Fuse Compartment Diskette Eject Button Diskette Drive Air Filter Cover...
Page 96: ......
Page 97: ......
Page 98: ......
Page 99: ...0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0...
Page 100: ......
Page 164: ......
Page 165: ......
Page 166: ......
Page 167: ...2 0 5 5 5 0 5 0 5 5 34 5 4 5 5 0 5 0 1 5 2 0 5 5 2 5 3 5 0 5 0 5...
Page 169: ......
Page 170: ......
Page 171: ......
Page 172: ......
Page 213: ......
Page 214: ......
Page 235: ......
Page 236: ......
Page 280: ......
Page 281: ......
Page 282: ......
Page 283: ...2 1 2 1 2 1 2 1 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 0 2 2 2 2...
Page 285: ......
Page 286: ......
Page 292: ......
Page 293: ......
Page 294: ......
Page 339: ......
Page 340: ......
Page 364: ......
Page 365: ......
Page 366: ......
Page 409: ......
Page 410: ......
Page 496: ......
Page 497: ......
Page 498: ......
Page 578: ......
Page 620: ......
Page 660: ......
Page 661: ......
Page 662: ......
Page 663: ......
Page 664: ......
Page 665: ......
Page 666: ......
Page 671: ......
Page 672: ......
Page 687: ......
Page 688: ......